Back to Results
First PageMeta Content
Waxman / Law / United States patent law / Government / Business / United States antitrust law / Federal Trade Commission / Drug Price Competition and Patent Term Restoration Act


No[removed]IN THE Supreme Court of the United States FEDERAL TRADE COMMISSION, Petitioner,
Add to Reading List

Document Date: 2013-03-07 13:42:35


Open Document

File Size: 271,07 KB

Share Result on Facebook

City

Washington / D.C. / St. Philadelphia / Washington / /

Company

RBC Capital Markets Corp. / Professional Real Estate Investors Inc. / CASES Abbott Laboratories / Geneva Pharmaceuticals Inc. / ACTAVIS INC. / Asahi Glass Co. Ltd. / Microsoft Corp. / Schering-Plough Corp. / Boston Scientific / Cited Authorities Page Valley Drug Co. / RESPONDENTS KRISTINA CAGGIANO DUANE MORRIS LLP / Watson Pharma / Columbia Pictures Inc. / Pentech Pharmaceuticals / Generic Co / ROBERT BYER DUANE MORRIS LLP / /

Continent

America / /

Country

United States / /

/

Facility

THE Supreme Court / Bar J. / /

IndustryTerm

antitrust law / patent law / law reviews / law professors / /

Organization

Congress / Supreme Court / Harvard / US Federal Reserve / United States FEDERAL TRADE COMMISSION / California Dental Association / Senate / Medicare / /

Person

Christopher M. Holman / Gregory Dolin / Kevin M. Murphy / Emily Michiko Morris / Gregory Glass / KENT BERNARD / Matthew J. Higgins / Kent S. Bernard / /

/

Position

Counsel / Walker / egbiester@duanemorris.com Counsel / /

Product

Tamoxifen Citrate / /

ProvinceOrState

Pennsylvania / D.C. / /

TVStation

Kyle / /

Technology

http / Drug Development / pdf / /

URL

http /

SocialTag